NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
Taking everything into account, DRUG scores 2 out of 10 in our technical rating. Although DRUG is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.
DRUG has a poor technical rating and the quality of the setup is also only medium at the moment. Prices have been consolidating lately and the volatility has been reduced.
28.54
We found 2 important support areas.
5 important resistance areas can be observed.
32.17
+1.55 (+5.06%)